P2RY13 and neoplasm: Recall that in the TMC cohort P2X3 was observed as the receptor with the greatest frequency of ‘high’ expression in HCC tumor samples (60%) and P2Y13 was identified as the receptor with the lowest frequency of ‘high’ expression (31%) (Figure 1D).